Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy
Objective Patients with brain metastases (BrMs) are a heterogeneous population, with almost 50% experiencing cognitive impairment before brain radiotherapy. Defining pre‐radiotherapy cognitive profiles will aid in understanding of the cognitive vulnerabilities and offer valuable insight and guidance...
Saved in:
Published in | Psycho-oncology (Chichester, England) Vol. 32; no. 11; pp. 1752 - 1761 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester
Wiley Subscription Services, Inc
01.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
Patients with brain metastases (BrMs) are a heterogeneous population, with almost 50% experiencing cognitive impairment before brain radiotherapy. Defining pre‐radiotherapy cognitive profiles will aid in understanding of the cognitive vulnerabilities and offer valuable insight and guidance for tailoring interventions.
Methods
The study population consisted of 58 adult patients with BrMs referred for radiotherapy. A semi‐structured interview and comprehensive battery including 10 neuropsychological tests were used to assess subjective and objective cognitive performance prior to radiotherapy.
Results
A majority (69%) of patients report decline in cognitive performance compared to their premorbid level (i.e. pre‐cancer). Objective testing revealed memory (52%), processing speed (33%) and emotion recognition (29%) deficits were most frequent. 21% of patients had no cognitive deficits while 55% had deficits (−1.5SD) in at least two cognitive domains. Hierarchical cluster analysis based on patient deficit profiles identified four clusters: (I) no or limited cognitive deficits selectively restricted to processing speed or executive function, (II) psychomotor speed deficits, (III) memory deficits and (IV) extensive cognitive deficits including memory. No patient or clinical‐related (e.g. age, number of BrMs, previous treatment) differences were found between clusters.
Conclusions
Patterns of cognitive performance in patients with BrMs are heterogeneous, with most experiencing at least some degree of neurocognitive dysfunction. We identified four meaningful cognitive clusters. Stability of these clusters over time and in different samples should be assessed to advance understanding of the cognitive vulnerability of this patient population. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1057-9249 1099-1611 |
DOI: | 10.1002/pon.6229 |